Skip survey header
English

ACUTE MYELOID LEUKEMIA NEEDS ASSESSMENT 2021

Identifying Unmet Needs and Clinical Challenges in Acute Myeloid Leukemia (AML)

Over the past few years, there have been significant advances in the management of AML, with several novel agents receiving Health Canada’s approval. This created a need to keep healthcare providers up to date on the recent developments and practical aspects associated with the integration of recently approved therapies into routine practice.

To determine educational needs, objectives, content, and the format for future AML-related educational initiatives, we ask you to complete a brief needs assessment questionnaire. The questionnaire is designed to assess the need for educational initiatives amongst different healthcare providers involved in the management of patients with AML.

This questionnaire should take about 20 minutes of your time, and responses will remain anonymous. You will be compensated 100 CAD for your contribution to this initiative.
PART 1. ABOUT YOUR PRACTICE
1. Please indicate the province in which you practice: *This question is required.
2. Your profession (please specify if needed): *This question is required.
3. Please indicate the type(s) of centre in which you practice (please select all that apply or the option closest to your type of centre): *This question is required.
4. Years of practice: *This question is required.
5. Number of patients with AML seen per year: *This question is required.